SEC 13F Intelligence

Highvista Strategies LLC / IMGNEUR

Highvista Strategies LLC’s Immunogen Inc Position

Does Highvista Strategies LLC own Immunogen Inc (IMGNEUR)? Not currently — the last reported position was 144.8K shares worth $4M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q4 2023
Shares
144.8K
% of Portfolio
+1.56%
Quarters Held
10
position exited

Position History IMGNEUR

Reported value by quarter
Q3 ’20: $96,000Q3 ’20Q4 ’20: $143,000Q1 ’21: $121,000Q1 ’21Q2 ’21: $99,000Q3 ’21: $137,000Q3 ’21Q1 ’22: $370,000Q2 ’22: $863,000Q2 ’22Q3 ’22: $311,000Q3 ’23: $2MQ3 ’23Q4 ’23: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 2023144.8K$4M+1.56%
Q3 2023144.8K$2M+1.06%
Q3 202265.2K$311,000+0.18%
Q2 2022191.7K$863,000+0.52%
Q1 202277.7K$370,000+0.24%
Q3 202124.1K$137,000+0.09%
Q2 202114.9K$99,000+0.07%
Q1 202114.9K$121,000+0.09%
Q4 202022.1K$143,000+0.09%
Q3 202026.8K$96,000+0.07%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of IMGNEUR.